[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-336914-105":59,"doc-detail-336914-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","analysis-of-modular-hub-genes-and-therapeutic-targets-across-stages-of-non-small-cell-lung-cancer-transcriptome","Analysis of Modular Hub Genes and Therapeutic Targets across Stages of Non-Small Cell Lung Cancer Transcriptome","","Non-small cell lung cancer (NSCLC), representing 85% of lung cancer cases, shows marked heterogeneity and stage-dependent progression. This study used Weighted Gene Coexpression Network Analysis (WGCNA) to uncover molecular mechanisms and nominate therapeutic targets. Gene expression data from the GEO database were compared across four NSCLC stages (NSCLC1–NSCLC4), using NSCLC2 for module preservation. Eight highly preserved modules were identified and linked to pathways such as cell cycle and cancer-related signaling. Hub genes including PLK1, CDK1, and EGFR supported roles in tumor proliferation and immune regulation, while ESR1 correlated with improved survival outcomes. Signature-based drug repurposing further highlighted candidates such as GW-5074 and olomoucine, as well as pinocembrin and citalopram, proposing new therapeutic directions.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/analysis-of-modular-hub-genes-and-therapeutic-targets-across-stages-of-non-small-cell-lung-cancer-transcriptome/336914/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/analysis-of-modular-hub-genes-and-therapeutic-targets-across-stages-of-non-small-cell-lung-cancer-transcriptome/336914.png","ImageObject",300,407,{"name":92,"@type":93},"Sage","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-06","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":39},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What analysis approach was used to study NSCLC stages?","Question",{"text":112,"@type":113},"The study applied Weighted Gene Coexpression Network Analysis (WGCNA) to investigate molecular mechanisms across four NSCLC stages using GEO transcriptome datasets.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"Which genes and pathway themes were highlighted as key regulators?",{"text":117,"@type":113},"Hub genes such as PLK1, CDK1, and EGFR were identified as critical regulators linked to tumor proliferation and immune responses, with enriched pathways including cell cycle and pathways in cancer.",{"name":119,"@type":110,"acceptedAnswer":120},"How was drug repurposing used to propose therapeutic candidates?",{"text":121,"@type":113},"Signature-based drug repurposing identified candidate drugs such as GW-5074 and olomoucine, and also highlighted pinocembrin and citalopram based on their predicted effects on NSCLC-related processes and signaling cascades.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},336914,1790387421,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":39,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},687197207057,"https://ap-avatar.wpscdn.com/davatar_29158cc5080c5b710cf443261637dec0","Article  \nAnalysis of Modular Hub Genes and Therapeutic Targets across Stages of Non-Small Cell Lung Cancer Transcriptome  \nAngeli Joy B. Barretto 1,2, Marco A. Orda 1,2, Po-wei Tsai 3 and Lemmuel L. Tayo 1,2,4, *  \nCitation: Barretto, A.J.B.; Orda, M.A.; Tsai, P.-w.; Tayo, L.L. Analysis of Modular Hub Genes and Therapeutic Targets across Stages of Non-Small Cell Lung Cancer Transcriptome. Genes 2024, 15, 1248. [https://doi.org/](https://doi.org/)[ ](https://doi.org/)[10.3390/genes15101248](10.3390/genes15101248)  \nAcademic Editors: Selvarangan Ponnazhagan, Albert Jeltsch and Sudheer Kumar Gara  \nReceived: 10 August 2024  \nRevised: 7 September 2024  \nAccepted: 23 September 2024  \nPublished: 25 September 2024  \nCopyright: © 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license ([https://](https://)[ ](https://)[creativecommons.org/licenses/by/](creativecommons.org/licenses/by/)[ ](creativecommons.org/licenses/by/)[4.0/](4.0/)) .  \n1 School of Chemical, Biological, and Materials Engineering and Sciences, Mapúa University, Manila City 1002,  \nPhilippines; [ajbbarretto@mymail.mapua.edu.ph](ajbbarretto@mymail.mapua.edu.ph) (A.J.B.B.); [maorda@mymail.mapua.edu.ph](maorda@mymail.mapua.edu.ph) (M.A.O.)  \n2 School of Graduate Studies, Mapúa University, Manila City 1002, Philippines  \n3 Department of Food Science, National Taiwan Ocean University, Keelung 20224, Taiwan; [powei@mail.ntou.edu.tw](powei@mail.ntou.edu.tw)  \n4 Department of Biology, School of Health Sciences, Mapúa University, Makati City 1203, Philippines  \n* Correspondence: [lltayo@mapua.edu.ph](lltayo@mapua.edu.ph)  \nAbstract: Non-small cell lung cancer (NSCLC), representing 85% of lung cancer cases, is characterized by its heterogeneity and progression through distinct stages. This study applied Weighted Gene Coexpression Network Analysis (WGCNA) to explore the molecular mechanisms of NSCLC and identify potential therapeutic targets. Gene expression data from the GEO database were analyzed across four NSCLC stages (NSCLC1, NSCLC2, NSCLC3, and NSCLC4), with the NSCLC2 dataset selected as the reference for module preservation analysis. WGCNA identified eight highly preserved modules—Cyan, Yellow, Red, Dark Turquoise, Turquoise, White, Purple, and Royal Blue—across datasets, which were enriched in key pathways such as “Cell cycle” and “Pathways in cancer”, involving processes like cell division and inflammatory responses. Hub genes, including PLK1, CDK1, and EGFR, emerged as critical regulators of tumor proliferation and immune responses. Estrogen receptor ESR1 was also highlighted, correlating with improved survival outcomes, suggesting its potential asa prognostic marker. Signature-based drug repurposing analysis identified promising therapeutic candidates, including GW-5074, which inhibits RAF and disrupts the EGFR–RAS–RAF–MEK–ERK signaling cascade, and olomoucine, a CDK1 inhibitor. Additional candidates like pinocembrin, which reduces NSCLC cell invasion by modulating epithelial-mesenchymal transition, and citalopram, an SSRI with anti-carcinogenic properties, were also identified. These findings provide valuable insights into the molecular underpinnings of NSCLC and suggest new directions for therapeutic strategies through drug repurposing.  \nKeywords: non-small cell lung cancer (NSCLC); WGCNA; KEGG pathways; module preservation; drug repurposing; GW-5074; olomoucine; pinocembrin; citalopram; cell cycle regulation; protein binding; estrogen  \n1. Introduction  \nNSCLC, or non-small cell lung cancer, accounts for over 85% of all cases of lung cancer and is one of the most common types [1,2] . This form of cancer is known for its heterogeneous nature, distinguishing it from small cell lung cancer (SCLC) by its typically slower progression and varied presentation. NSCLC is broadly classified into several subtypes based on histological chara","cbCaiagfYbw10wea","https://ap.wps.com/l/cbCaiagfYbw10wea","pdf",3580252,25,"English","# Introduction\n## NSCLC background and stages\n## NSCLC treatment overview\n# Methods\n## WGCNA analysis across GEO datasets\n## Module preservation using NSCLC2 reference\n# Results\n## Preserved coexpression modules and pathway enrichment\n## Hub genes and ESR1 prognostic relevance\n## Drug repurposing candidates and mechanisms\n# Conclusion","[{\"question\":\"What analysis approach was used to study NSCLC stages?\",\"answer\":\"The study applied Weighted Gene Coexpression Network Analysis (WGCNA) to investigate molecular mechanisms across four NSCLC stages using GEO transcriptome datasets.\"},{\"question\":\"Which genes and pathway themes were highlighted as key regulators?\",\"answer\":\"Hub genes such as PLK1, CDK1, and EGFR were identified as critical regulators linked to tumor proliferation and immune responses, with enriched pathways including cell cycle and pathways in cancer.\"},{\"question\":\"How was drug repurposing used to propose therapeutic candidates?\",\"answer\":\"Signature-based drug repurposing identified candidate drugs such as GW-5074 and olomoucine, and also highlighted pinocembrin and citalopram based on their predicted effects on NSCLC-related processes and signaling cascades.\"}]","Analysis of Modular Hub Genes and Therapeutic Targets across Stages of Non-Small Cell Lung Cancer Transcriptome | PDF",1790017043,63,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/bd6f85cdbbb031cd96423cf221fdea08.webp",983,1390,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/5cb028f160a247b91ca69e6ce0eea36d.webp",982,1388,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f3dbec1bbb1365f1de4f72ac59ecac01.webp",981,1387,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c8ff1c07267ec2f070d37164396f689e.webp",980,1385]